Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03089281 · ClinicalTrials.gov registry record · NA
Strategic Management to Optimize Response To Cardiac Resynchronization Therapy
A NA study of Heart Failure, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 699
- Enrollment target
- 20
- Study locations
NCT03089281 is a NA study of Heart Failure that has completed, run by Boston Scientific Corporation. The registered enrollment target is 699 participants, below the 2,047-participant average among 397 other Heart Failure trials with a reported enrollment target (66% lower). The trial reports 20 study locations across 12 states.
The verdict
NCT03089281, a NA study of Heart Failure, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 699 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary objective is to evaluate the benefit of the SmartDelay™ algorithm in patients with a prolonged RV-LV interval.
Conditions Studied
Interventions
- DEVICE CRT-D
Study Locations (20)
Florida
- Baptist Health Research Institute - Jacksonville
- Watson Clinic Center for Research, Inc - Lakeland
- Winter Haven Hospital - Winter Haven
Alabama
- Affinity Hospital, LLC d/b/a Granview Medical Center - Birmingham
- Heart Center Research LLC - Huntsville
California
- Glendale Adventist Medical Center - Glendale
- Salinas Valley Memorial Healthcare System - Salinas
Georgia
- Emory University Hospital - Atlanta
- Northside Hospital - Atlanta
Illinois
- The University of Chicago - Chicago
- St. John's Hospital - Springfield
Kentucky
- St. Elizabeth Healthcare - Edgewood
- Baptist Health Lexington - Lexington
Massachusetts
- Lahey Hospital and Medical Center - Burlington
- Southcoast Health - Fall River
Arizona
- University of Arizona Sarver Heart Center - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 699 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2020-09-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03089281
The ClinicalTrials.gov registry entry for NCT03089281 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 699 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,047-participant average among 397 other Heart Failure trials with a reported enrollment target (66% lower). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which CRT-D is the first listed.
NCT03089281 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Florida, Alabama, California.
Frequently Asked Questions
What is clinical trial NCT03089281 about?
NCT03089281 is a clinical study titled "Strategic Management to Optimize Response To Cardiac Resynchronization Therapy". The primary objective is to evaluate the benefit of the SmartDelay™ algorithm in patients with a prolonged RV-LV interval.
What is the current status of trial NCT03089281?
This trial is currently completed. It is a NA study. The enrollment target is 699 participants. The study started on 2017-08-01. Estimated completion is 2020-09-15.
What conditions does trial NCT03089281 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT03089281?
The interventions under investigation include: CRT-D (DEVICE).
Who is sponsoring clinical trial NCT03089281?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03089281 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.